Protagenic Therapeutics Capital Reinvestment Ratio
Protagenic Therapeutics capital reinvestment ratio. Protagenic Therapeutics (PTIX) has a Capital Reinvestment Ratio of 0.11x as of September 2008, meaning it reinvests 0% of its operating cash flow ($6.90 Million) in capital expenditures ($765.00K). Check Protagenic Therapeutics total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Protagenic Therapeutics (1999–2008)
Capital reinvestment ratio of Protagenic Therapeutics from 1999 to 2008. This chart tracks Protagenic Therapeutics's Capital Reinvestment Ratio across 7 annual periods. Also explore PTIX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Protagenic Therapeutics Capital Reinvestment Ratio by Year (1999–2008)
Protagenic Therapeutics capital reinvestment ratio by year from 1999 to 2008. For the full cash flow conversion analysis, see PTIX cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2008 | 0.47x | $4.36 Million | $2.03 Million | ▲ +463.3% |
| 2006 | 0.08x | $931.00K | $77.00K | ▼ -89.5% |
| 2003 | 0.79x | $1.87 Million | $1.48 Million | ▲ +4.1% |
| 2002 | 0.76x | $2.35 Million | $1.78 Million | ▼ -69.8% |
| 2001 | 2.52x | $1.50 Million | $3.79 Million | ▲ +173.6% |
| 2000 | 0.92x | $3.51 Million | $3.23 Million | ▲ +276.3% |
| 1999 | 0.24x | $331.00K | $81.00K | — |